Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone H3K27me2/H3K27me3 demethylase activity

PHF8 UTY

2.13e-045932GO:0071558
GeneOntologyMolecularFunctionMAP kinase kinase kinase activity

RAF1 ARAF MAP3K1

2.64e-0427933GO:0004709
GeneOntologyMolecularFunctionhistone H3 demethylase activity

PHF8 JMJD1C UTY

2.94e-0428933GO:0141052
GeneOntologyMolecularFunctionhistone demethylase activity

PHF8 JMJD1C UTY

4.00e-0431933GO:0032452
GeneOntologyMolecularFunctionprotein demethylase activity

PHF8 JMJD1C UTY

4.40e-0432933GO:0140457
GeneOntologyMolecularFunctionadenylate cyclase regulator activity

RAF1 GRM7

7.56e-049932GO:0010854
GeneOntologyMolecularFunctionprotein-glutamic acid ligase activity

TTLL7 TTLL2

9.42e-0410932GO:0070739
GeneOntologyMolecularFunctiontubulin-glutamic acid ligase activity

TTLL7 TTLL2

9.42e-0410932GO:0070740
GeneOntologyMolecularFunctiondemethylase activity

PHF8 JMJD1C UTY

1.13e-0344933GO:0032451
GeneOntologyMolecularFunctionhistone H3K36 demethylase activity

PHF8 UTY

1.15e-0311932GO:0051864
GeneOntologyMolecularFunctionvoltage-gated chloride channel activity

CLCN3 CLCN7

1.15e-0311932GO:0005247
GeneOntologyMolecularFunctionprotein serine kinase activity

RAF1 ARAF MAP3K1 MYO3A STK38L ULK2 ALPK2

1.54e-03363937GO:0106310
GeneOntologyMolecularFunctionvoltage-gated monoatomic ion channel activity

GRM7 CLCN3 CLCN7 KCNS3 KCNT1

1.62e-03182935GO:0005244
GeneOntologyMolecularFunctionvoltage-gated channel activity

GRM7 CLCN3 CLCN7 KCNS3 KCNT1

1.70e-03184935GO:0022832
GeneOntologyMolecularFunctioncytoskeletal protein binding

MAP7D3 PICALM MAP3K1 TTLL7 MYO3A PTPRN ARHGEF10 TTLL2 FARP1 SIPA1L1 KIF19 STK38L ALDOB

1.71e-0310999313GO:0008092
GeneOntologyMolecularFunctionhistone H3K9 demethylase activity

PHF8 JMJD1C

1.88e-0314932GO:0032454
HumanPhenoAbnormality of the female genitalia

RAF1 HSPG2 ROR2 DDB1 JMJD1C MAP3K1 ORC4 FREM2 NPHP3 PNPLA6 GLI2 PTCH2 FIGLA

5.30e-057412813HP:0010460
HumanPhenoAbnormal testis morphology

THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

6.01e-0511292816HP:0000035
HumanPhenoNon-obstructive azoospermia

THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

6.22e-0511322816HP:0011961
HumanPhenoAzoospermia

THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

8.26e-0511572816HP:0000027
HumanPhenoCryptorchidism

RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

9.19e-057802813HP:0000028
HumanPhenoAbnormal male external genitalia morphology

THSD4 RAF1 HSPG2 ROR2 PHF8 GRM7 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

1.12e-0413292817HP:0000032
HumanPhenoAbnormal spermatogenesis

THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

1.18e-0411902816HP:0008669
HumanPhenoAbnormal internal genitalia

THSD4 RAF1 HSPG2 ROR2 PHF8 DDB1 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 FIGLA CPLANE1

1.32e-0414982818HP:0000812
HumanPhenoAbnormal external genitalia

THSD4 RAF1 HSPG2 ROR2 PHF8 GRM7 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

1.72e-0413722817HP:0000811
HumanPhenoAbnormal male internal genitalia morphology

THSD4 RAF1 HSPG2 ROR2 PHF8 JMJD1C MAP3K1 ORC4 FREM2 EYS NPHP3 PNPLA6 CLCN3 GLI2 PTCH2 CPLANE1

2.06e-0412432816HP:0000022
HumanPhenoEpicanthus

RAF1 HSPG2 ROR2 DDB1 JMJD1C PNPLA6 CLCN3 CLCN7 GLI2 PTCH2 CPLANE1

2.21e-046142811HP:0000286
DomainDUF1712

CCZ1B CCZ1

2.40e-052922PF08217
DomainDUF1712_fun

CCZ1B CCZ1

2.40e-052922IPR013176
DomainJmjC

PHF8 JMJD1C UTY

2.17e-0424923PF02373
DomainRBD

RAF1 ARAF

3.55e-046922PF02196
DomainRBD

RAF1 ARAF

4.96e-047922SM00455
DomainRBD_dom

RAF1 ARAF

4.96e-047922IPR003116
DomainRBD

RAF1 ARAF

4.96e-047922PS50898
DomainJMJC

PHF8 JMJD1C UTY

5.17e-0432923PS51184
DomainJmjC_dom

PHF8 JMJD1C UTY

5.17e-0432923IPR003347
DomainJmjC

PHF8 JMJD1C UTY

5.67e-0433923SM00558
DomainCl-channel_core

CLCN3 CLCN7

8.45e-049922IPR014743
Domain-

CLCN3 CLCN7

8.45e-0499221.10.3080.10
DomainVoltage_CLC

CLCN3 CLCN7

8.45e-049922PF00654
DomainCl-channel_volt-gated

CLCN3 CLCN7

8.45e-049922IPR001807
DomainRap_GAP

RALGAPA2 SIPA1L1

1.05e-0310922PF02145
DomainRap_GAP_dom

RALGAPA2 SIPA1L1

1.28e-0311922IPR000331
DomainRAPGAP

RALGAPA2 SIPA1L1

1.28e-0311922PS50085
DomainLaminin_G_1

HSPG2 EYS

1.28e-0311922PF00054
DomainTTL

TTLL7 TTLL2

1.81e-0313922PS51221
DomainTTL/TTLL_fam

TTLL7 TTLL2

1.81e-0313922IPR004344
DomainTTL

TTLL7 TTLL2

1.81e-0313922PF03133
DomainSEA

HSPG2 MUC16

2.10e-0314922SM00200
DomainIg_I-set

HSPG2 ROR2 IGSF10 LRIG1 ALPK2

2.49e-03190925IPR013098
DomainI-set

HSPG2 ROR2 IGSF10 LRIG1 ALPK2

2.49e-03190925PF07679
DomainCBS

CLCN3 CLCN7

2.75e-0316922SM00116
DomainCBS_dom

CLCN3 CLCN7

4.30e-0320922IPR000644
DomainCBS

CLCN3 CLCN7

4.30e-0320922PF00571
DomainCBS

CLCN3 CLCN7

4.30e-0320922PS51371
DomainDAG/PE-bd

RAF1 ARAF

4.74e-0321922IPR020454
DomainSEA

HSPG2 MUC16

5.20e-0322922PF01390
DomainKinase-like_dom

RAF1 ROR2 ARAF MAP3K1 MYO3A STK38L ULK2 ALPK2

5.27e-03542928IPR011009
DomainSEA

HSPG2 MUC16

5.68e-0323922PS50024
DomainSEA_dom

HSPG2 MUC16

5.68e-0323922IPR000082
DomainIGc2

HSPG2 ROR2 IGSF10 LRIG1 ALPK2

6.12e-03235925SM00408
DomainIg_sub2

HSPG2 ROR2 IGSF10 LRIG1 ALPK2

6.12e-03235925IPR003598
PathwayWP_MAPK_CASCADE

RAF1 ARAF MAP3K1

3.09e-0428673MM15976
PathwayREACTOME_OLFACTORY_SIGNALING_PATHWAY

OR4L1 OR10G7 OR10G4 OR10G9

3.38e-0470674MM14984
PathwayREACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION

GLI2 PTCH2

4.60e-047672M27501
PathwayWP_MAPK_CASCADE

RAF1 ARAF MAP3K1

5.06e-0433673M39594
PathwayREACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS

RAF1 ARAF

6.12e-048672M38999
PathwayKEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE

RAF1 ARAF

6.12e-048672M47933
PathwayWP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING

RAF1 IFITM2 MAP3K1

6.55e-0436673M39908
PathwayWP_HEPATITIS_B_INFECTION

RAF1 HSPG2 DDB1 ARAF MAP3K1

7.47e-04151675M39801
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY

RAF1 ARAF

9.77e-0410672M47374
PathwayKEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY

RAF1 ARAF

9.77e-0410672M47420
PathwayKEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY

RAF1 ARAF

9.77e-0410672M47735
PathwayKEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.19e-0311672M47370
PathwayKEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.19e-0311672M47371
PathwayWP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ

RAF1 MAP3K1

1.42e-0312672M39552
PathwayKEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.42e-0312672M47369
PathwayKEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.42e-0312672M47597
PathwayKEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.42e-0312672M47815
PathwayKEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.68e-0313672M47589
PathwayKEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.95e-0314672M47364
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.95e-0314672M47365
PathwayKEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.95e-0314672M47366
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.95e-0314672M47378
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.95e-0314672M47383
PathwayKEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.95e-0314672M47384
PathwayKEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY

GLI2 PTCH2

1.95e-0314672M47414
PathwayKEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

1.95e-0314672M47488
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47367
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47375
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47382
PathwayKEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47380
PathwayKEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47592
PathwayKEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47593
PathwayKEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47640
PathwayKEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47485
PathwayKEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47473
PathwayKEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47474
PathwayKEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47480
PathwayKEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47495
PathwayKEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47496
PathwayKEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47497
PathwayKEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47472
PathwayKEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47535
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.25e-0315672M47531
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.56e-0316672M47363
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.56e-0316672M47373
PathwayKEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.56e-0316672M47381
PathwayKEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.56e-0316672M47804
PathwayKEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.56e-0316672M47801
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC16 MUC4

2.56e-0316672M27410
PathwayWP_HEDGEHOG_SIGNALING_WP47

GLI2 PTCH2

2.56e-0316672M39675
PathwayKEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.56e-0316672M47483
PathwayKEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY

RAF1 ARAF

2.56e-0316672M47682
PathwayKEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY

RAF1 ARAF

2.89e-0317672M47376
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC16 MUC4

2.89e-0317672M27412
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY

RAF1 ARAF

2.89e-0317672M47684
Pubmed

Mammalian Ras interacts directly with the serine/threonine kinase Raf.

RAF1 ARAF

7.70e-0629728334704
Pubmed

A-Raf and C-Raf differentially regulate mechanobiological response of osteoblasts to guide mechanical stress-induced differentiation.

RAF1 ARAF

7.70e-06297227240957
Pubmed

Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.

KRT7 MUC16

7.70e-06297218317225
Pubmed

Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.

MUC16 MUC4

7.70e-06297223544943
Pubmed

A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression.

RAF1 ARAF

7.70e-06297215856007
Pubmed

Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.

RAF1 MAP3K1

7.70e-06297222110214
Pubmed

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.

RAF1 ARAF

2.31e-05397220130576
Pubmed

Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.

MUC16 MUC4

2.31e-05397223053434
Pubmed

Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.

CLCN3 CLCN7

2.31e-05397215706348
Pubmed

Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.

RAF1 ARAF

2.31e-05397214688025
Pubmed

Expression of raf family proto-oncogenes in normal mouse tissues.

RAF1 ARAF

2.31e-0539721690378
Pubmed

PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation.

CCZ1B CCZ1

2.31e-05397232160108
Pubmed

Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.

RAF1 ARAF

2.31e-05397220052757
Pubmed

Endothelial apoptosis in Braf-deficient mice.

RAF1 ARAF

2.31e-0539729207797
Pubmed

Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.

MUC16 MUC4

2.31e-05397230236127
Pubmed

Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.

MUC16 MUC4

2.31e-05397217592322
Pubmed

Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling.

RAF1 ARAF

2.31e-05397223352452
Pubmed

Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis.

RAF1 ARAF

2.31e-05397210704835
Pubmed

ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.

RAF1 ARAF

2.31e-05397222926515
Pubmed

Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.

MUC16 MUC4

2.31e-05397235879412
Pubmed

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).

MUC16 MUC4

2.31e-05397227483328
Pubmed

MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.

MUC16 MUC4

2.31e-05397224204560
Pubmed

Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.

MUC16 MUC4

2.31e-05397224939955
Pubmed

Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function.

KRT7 PKHD1

2.31e-05397218235088
Pubmed

Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.

THSD4 HSPG2 WDR76 DDB1 PICALM FREM2

3.57e-0521997631353912
Pubmed

Primary cilia in murine palatal rugae development.

ROR2 GLI2 PTCH2

3.58e-052397331226309
Pubmed

Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins.

RAF1 ARAF

4.60e-0549728394352
Pubmed

Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

RAF1 MAP3K1

4.60e-05497217397260
Pubmed

Identification of interaction between MEK2 and A-Raf-1.

RAF1 ARAF

4.60e-05497211909642
Pubmed

Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells.

RAF1 ARAF

4.60e-0549728621729
Pubmed

Aberrant expression of COT is related to recurrence of papillary thyroid cancer.

RAF1 ARAF

4.60e-05497225674762
Pubmed

Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters.

CLCN3 CLCN7

4.60e-05497217110406
Pubmed

B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.

RAF1 ARAF

4.60e-0549727731720
Pubmed

Functional characterization of a PROTAC directed against BRAF mutant V600E.

RAF1 ARAF

4.60e-05497232778845
Pubmed

A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf.

RAF1 MAP3K1

4.60e-0549728385802
Pubmed

TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.

MUC16 MUC4

4.60e-05497239024979
Pubmed

Identification of two evolutionarily conserved genes regulating processing of engulfed apoptotic cells.

CCZ1B CCZ1

4.60e-05497220305638
Pubmed

Human adolescent nephronophthisis: gene locus synteny with polycystic kidney disease in pcy mice.

NPHP3 TMEM108

7.66e-05597211134256
Pubmed

Germline gain-of-function mutations in RAF1 cause Noonan syndrome.

RAF1 ARAF

7.66e-05597217603482
Pubmed

In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice.

RAF1 ARAF

7.66e-05597217219248
Pubmed

Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors.

RAF1 ARAF

7.66e-05597224746704
Pubmed

Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors.

RAF1 DDB1 ARAF

8.08e-053097334017080
Pubmed

Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1.

RAF1 ARAF

1.15e-0469728157000
Pubmed

Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma.

GLI2 PTCH2

1.15e-04697219487286
Pubmed

Isoform-specific localization of A-RAF in mitochondria.

RAF1 ARAF

1.15e-04697210848612
Pubmed

MEKK1-Dependent Activation of the CRL4 Complex Is Important for DNA Damage-Induced Degradation of p21 and DDB2 and Cell Survival.

DDB1 MAP3K1

1.15e-04697234251884
Pubmed

Wound-healing plasticity enables clonal expansion of founder progenitor cells in colitis.

KRT7 LRIG1

1.15e-04697237652012
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

MAP7D3 HUS1 ECD PHF8 DDB1 ARAF FARP1 SIPA1L1 CPLANE1 GARRE1

1.37e-04853971028718761
Pubmed

Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.

RAF1 MAP7D3 ARAF

1.40e-043697335379950
Pubmed

Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.

CCDC80 DNAAF9 WDR76 PICALM CRHR2 FREM2 CCZ1 ARHGEF10 FER1L4 RIPOR1 MMS19 HOMER3

1.45e-041215971215146197
Pubmed

Identification of Nore1 as a potential Ras effector.

RAF1 ARAF

1.60e-0479729488663
Pubmed

An ARL3-UNC119-RP2 GTPase cycle targets myristoylated NPHP3 to the primary cilium.

DNAAF9 NPHP3

1.60e-04797222085962
Pubmed

Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation.

RAF1 MAP3K1

1.60e-04797221336309
Pubmed

Lysine acetylation targets protein complexes and co-regulates major cellular functions.

RAF1 ARAF CCZ1

1.65e-043897319608861
Pubmed

JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension.

RAF1 MAP3K1

2.13e-0489729808624
Pubmed

A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse model.

GLI2 PTCH2

2.13e-04897222869526
Pubmed

Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1.

GLI2 PTCH2

2.13e-04897210529434
Pubmed

MEKK1 binds raf-1 and the ERK2 cascade components.

RAF1 MAP3K1

2.13e-04897210969079
Pubmed

Expression of hedgehog signalling components in adult mouse testis.

GLI2 PTCH2

2.13e-04897216958114
Pubmed

3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development.

HSPG2 FREM2

2.13e-04897233875569
Pubmed

Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog.

GLI2 PTCH2

2.13e-04897210027293
Pubmed

Human DNA polymerase ε is phosphorylated at serine-1940 after DNA damage and interacts with the iron-sulfur complex chaperones CIAO1 and MMS19.

DDB1 MMS19

2.13e-04897227235625
Pubmed

Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation.

RAF1 ARAF

2.74e-04997219667065
Pubmed

AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.

RAF1 ARAF

2.74e-04997230595535
Pubmed

A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes.

RAF1 ARAF

2.74e-04997217967876
Pubmed

Phosphorylation-dependent interaction of kinesin light chain 2 and the 14-3-3 protein.

RAF1 ARAF

2.74e-04997211969417
Pubmed

Changing expression of chloride channels during preimplantation mouse development.

CLCN3 CLCN7

2.74e-04997223115349
Pubmed

JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.

RAF1 MAP3K1

2.74e-04997210523642
Pubmed

Autonomous and non-autonomous Shh signalling mediate the in vivo growth and guidance of mouse retinal ganglion cell axons.

GLI2 PTCH2

2.74e-04997218832395
Pubmed

Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases.

RAF1 MAP3K1

2.74e-04997215866172
Pubmed

Diverse roles of E-cadherin in the morphogenesis of the submandibular gland: insights into the formation of acinar and ductal structures.

HSPG2 KRT7

2.74e-04997218816447
Pubmed

Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation.

RAF1 GLI2 PTCH2

3.12e-044797332747435
Pubmed

The Shh signalling pathway in early tooth development.

GLI2 PTCH2

3.41e-041097210512189
Pubmed

Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.

RAF1 MAP3K1

3.41e-041097215192046
Pubmed

Gastrin transactivates the chromogranin A gene through MEK-1/ERK- and PKC-dependent phosphorylation of Sp1 and CREB.

RAF1 MAP3K1

3.41e-041097217889508
Pubmed

Essential role of B-Raf in ERK activation during extraembryonic development.

RAF1 ARAF

3.41e-041097216432225
Pubmed

Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling.

GLI2 PTCH2

3.41e-041097228344083
Pubmed

PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12.

PRR5 ARAF

3.41e-041097222609986
Pubmed

Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.

PHF8 JMJD1C UTY

3.53e-044997334368113
Pubmed

Mass spectrometry-based proteomic analysis of FSCN1-interacting proteins in laryngeal squamous cell carcinoma cells.

PICALM ARAF PNPLA6 MMS19

3.65e-0412097431298480
Pubmed

Evidence that preaxial polydactyly in the Doublefoot mutant is due to ectopic Indian Hedgehog signaling.

GLI2 PTCH2

4.17e-04119729671585
Pubmed

Runx2 (Cbfa1) inhibits Shh signaling in the lower but not upper molars of mouse embryos and prevents the budding of putative successional teeth.

GLI2 PTCH2

4.17e-041197215668330
Pubmed

Congenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY

NPHP3 PKHD1 CPLANE1

4.21e-045297320301743
Pubmed

Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1.

GLI2 PTCH2

4.99e-041297211389830
Pubmed

Lhx2 is a progenitor-intrinsic modulator of Sonic Hedgehog signaling during early retinal neurogenesis.

GLI2 PTCH2

4.99e-041297236459481
Pubmed

Paracrine Hedgehog signaling in stomach and intestine: new roles for hedgehog in gastrointestinal patterning.

GLI2 PTCH2

4.99e-041297219445942
Pubmed

Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte.

GLI2 PTCH2

4.99e-041297210981962
Pubmed

Vsx2/Chx10 ensures the correct timing and magnitude of Hedgehog signaling in the mouse retina.

GLI2 PTCH2

4.99e-041297218417110
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

HSPG2 RHBDF1 RALGAPA2 GLCCI1 LRIG1 FARP1

5.52e-0436397614691545
Pubmed

Expression patterns of Hedgehog signalling pathway members during mouse palate development.

GLI2 PTCH2

5.89e-041397216168717
Pubmed

A targeted multienzyme mechanism for selective microtubule polyglutamylation.

TTLL7 TTLL2

5.89e-041397217499049
Pubmed

Residual embryonic cells as precursors of a Barrett's-like metaplasia.

KRT7 MUC4

5.89e-041397221703447
Pubmed

Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development.

GLI2 PTCH2

5.89e-041397225448692
Pubmed

Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci.

MAP3K1 ALDOB

5.89e-041397225352737
Pubmed

Ptch2/Gas1 and Ptch1/Boc differentially regulate Hedgehog signalling in murine primordial germ cell migration.

GLI2 PTCH2

5.89e-041397232332736
Pubmed

TFEB regulates murine liver cell fate during development and regeneration.

KRT7 ALDOB

5.89e-041397232424153
Pubmed

Gli2 influences proliferation in the developing lung through regulation of cyclin expression.

GLI2 PTCH2

5.89e-041397219574535
Pubmed

Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.

DDB1 NPHP3

5.89e-041397222863007
Pubmed

FOXD1 is required for 3D patterning of the kidney interstitial matrix.

HSPG2 FREM2

5.89e-041397236335435
Pubmed

Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

ECD DDB1 JMJD1C ORC4 GARRE1

5.99e-0424297534011540
GeneFamilyMitogen-activated protein kinase kinase kinases|RAF family

RAF1 ARAF MAP3K1

7.38e-0524623654
GeneFamilyPHD finger proteins|Lysine demethylases

PHF8 JMJD1C UTY

7.38e-0524623485
GeneFamilyMitogen-activated protein kinase kinase kinases|RAF family

RAF1 ARAF

1.15e-0456221157
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

HSPG2 ROR2 IGSF10 LRIG1 ALPK2

2.26e-04161625593
GeneFamilyChloride voltage-gated channels

CLCN3 CLCN7

5.12e-0410622302
GeneFamilyTubulin tyrosine ligase family

TTLL7 TTLL2

1.03e-0314622779
GeneFamilyOlfactory receptors, family 10

OR10G7 OR10G4 OR10G9

1.51e-0366623157
GeneFamilyEF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2

DDB1 MMS19

1.71e-03186221269
GeneFamilyCD molecules|Mucins

MUC16 MUC4

2.33e-0321622648
CoexpressionAtlasdev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200

KRT7 MUC16 FREM2 TMEM108

9.82e-0633874gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_200
ToppCellNS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KRT7 MUC16 CCDC80 EHF SLC5A8 CPLANE1 MUC4

2.46e-07198967a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 KRT7 MUC16 CCDC80 FREM2 TMEM108

1.68e-061679667abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 KRT7 MUC16 CCDC80 FREM2 TMEM108

1.68e-06167966d50311b1f66f143bae4c4cf50e2e9b13c85d6920
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 HSPG2 ROR2 CCDC80 WDR43 GLI2

1.93e-06171966972fab891135bd755d5526cbc5a963200067b0a6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 HSPG2 ROR2 CCDC80 WDR43 GLI2

1.93e-061719662a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KRT7 ADGRG4 EYS PTPRN DSG4 SLC5A8

2.28e-061769662e1003dc373b14d27f0464d980453fdcfc1005f0
ToppCellAdult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor

LRIG1 FARP1 EHF TMEM108 MUC4 UTY

2.43e-0617896635a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor

GLCCI1 LRIG1 FARP1 EHF TMEM108 MUC4

3.04e-06185966673f0c688ae6984bc8027df2da335787924f4137
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 MUC16 C2orf66 EHF SLC5A8 MUC4

3.33e-061889665901b276f2379abf486b8285957277e95f08464e
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

THEMIS2 KRT7 TCIM GRM7 MAP3K1 PKHD1

3.44e-06189966aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

THEMIS2 KRT7 TCIM GRM7 MAP3K1 PKHD1

3.44e-061899668977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MAP3K1 TTLL7 MYO3A FARP1 PKHD1 ALPK2

3.65e-061919661cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCellCOVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type

HSPG2 E2F7 IFITM2 RALGAPA2 SIPA1L1 TMEM108

3.76e-06192966c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCellNS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KRT7 MUC16 CCDC80 EHF SLC5A8 MUC4

3.76e-0619296602b11233b4da2d85b96498b3c6e22e3a31b3d049
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

ATXN7L1 DNAAF9 JMJD1C FARP1 SIPA1L1 PKHD1

3.76e-06192966e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KRT7 MAP3K1 FARP1 PKHD1 SLC5A8 ALPK2

3.88e-06193966ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

GRM7 IGSF10 LRIG1 KIF19 CPLANE1 CDHR4

3.88e-06193966ea345d34440b25f65358a53dc72831998d1c3620
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THSD4 KRT7 CLCN3 EHF SLC5A8 MUC4

3.88e-061939661526f51b589a7dc7a28f35f0e788dc38d338d2bc
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ROR2 TCIM MAP3K1 CLCN3 GLI2 FARP1

3.99e-06194966b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCellNS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

HSPG2 KRT7 TCIM MUC16 KCNS3 MUC4

4.11e-06195966b0d782eeee30c797b4da9b3be29b864983fd9e71
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 CCDC80 KIF19 CPLANE1 MUC4 CDHR4

4.11e-0619596679dc031258579ea328181dda33710dd897f1064a
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KRT7 RHBDF1 TCIM MUC16 EHF MUC4

4.24e-06196966b246e482f012dd9782b49c2a953acedfa3c1139d
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KRT7 RHBDF1 TCIM MUC16 EHF MUC4

4.24e-06196966808c0a7d1889a8f3508ed9790c6dc7ec16bbc840
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 MUC16 CCDC80 EHF CPLANE1 MUC4

4.36e-061979665c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCellMild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30)

KRT7 RHBDF1 MUC16 EHF SLC5A8 MUC4

4.36e-061979664cc5b778e1e2c6c149160fa147c172977c0fa8eb
ToppCellNasal_Brush-Epithelial|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

KRT7 MUC16 CCDC80 EHF SLC5A8 MUC4

4.76e-062009667911073119ee47a37b68b73fc54f063e902a5067
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type.

THSD4 E2F7 ARAF FREM2 CLCN7 GLI2

4.76e-06200966b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef
ToppCellCOVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type

GRM7 RFX4 OR10G7 EYS PKHD1

9.23e-061309651ff28e9d3dc9a791e07d815f8fbb48f75d3f275b
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

RHBDF1 SZT2 EYS KIF19 ALPK2

1.07e-0513496572d7eec3aeb43319f3ef81bb5518fae8d8880136
ToppCellmoderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

RHBDF1 TCIM MUC16 PTCH2 MUC4

1.23e-05138965afefa8233c67aa744e939156bc538449bf6bd05b
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32

THEMIS2 RGSL1 FSBP ALPK2

1.60e-05709642121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

THEMIS2 RGSL1 FSBP ALPK2

1.60e-0570964cd6bca68fe52f451716fc8c0b1745984bc9ec057
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

THEMIS2 RGSL1 FSBP ALPK2

1.60e-0570964be300c0447735aba89df4c3082b81eb5abf22770
ToppCellfacs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THSD4 NMNAT2 RUBCNL GRM7 KCNS3

3.86e-051759659a96794df049d8228fea57c1584c160191d36b56
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 ROR2 CCDC80 IGSF10 GLI2

3.97e-051769659bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 ROR2 CCDC80 IGSF10 GLI2

3.97e-051769653f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ROR2 TCIM ARMS2 FREM2 MYO3A

4.19e-05178965f332c7a96844abecf05ca057480fbea9296688a2
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 MUC16 CCDC80 FREM2 TMEM108

4.19e-05178965a107dd98a07086ed0429116095ecda60c9dbef1e
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 MUC16 CCDC80 FREM2 TMEM108

4.19e-05178965bcbdd45a2307f8aea14122fa0144b96b1f6eec48
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

THSD4 MUC16 CCDC80 FREM2 TMEM108

4.19e-05178965c413861148129be1ee94f2ceb5999840217eebe5
ToppCellCOVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

GRM7 MYO3A FARP1 PKHD1 ALPK2

4.19e-05178965544379f5a6145429762258d426b876bb36c112f5
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCDC80 TTLL7 ARHGEF10 MMS19 UTY

4.30e-05179965025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROR2 CCDC80 IGSF10 GLI2 TMEM108

4.41e-0518096508ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCDC80 GRM7 KIF19 MUC4 CDHR4

4.41e-051809651f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCellP03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

KRT7 MUC16 CCDC80 FREM2 TMEM108

4.41e-051809652ccc77d769d3ffd77ab3af45e4f192785b6db79c
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

E2F7 RFX4 LRIG1 GLI2 PTCH2

4.65e-05182965904804813849b7f7f716ba1554d33b07bc0a701e
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

E2F7 RFX4 LRIG1 GLI2 PTCH2

4.65e-051829655d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD4 NMNAT2 ROR2 CCDC80 GLI2

4.77e-051839657eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RUBCNL TCIM EYS KCNS3 TMEM108

4.90e-051849652ba98708dfd7f1b2a661578a334684094ff453ad
ToppCellE17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

THSD4 MUC16 CCDC80 FREM2 TMEM108

4.90e-05184965607b55022de21ddb6a2d75e085df76df7abf6624
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor

GLCCI1 LRIG1 FARP1 EHF TMEM108

5.03e-0518596598b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor

THSD4 KRT7 TTLL7 FARP1 CPLANE1

5.03e-0518596532b4e68e551d435a732f253f6ad83408c759a642
ToppCellCOVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations)

THSD4 LRIG1 FARP1 EHF MUC4

5.03e-05185965cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCellCOVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

FARP1 PKHD1 SLC5A8 ALDOB ALPK2

5.03e-051859651bbc2ba8a20f72f61981b1301cdd6018cdd9150d
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RUBCNL TCIM KCNS3 TMEM108 HOMER3

5.16e-05186965948815663c212c4311329d503b5991cbbbff9808
ToppCell(5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

THEMIS2 KRT7 RUBCNL TCIM MUC16

5.16e-05186965219b1aeca17503244fabbb780bca58f22c7c0f27
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP3K1 FREM2 FARP1 PKHD1 ALPK2

5.16e-051869655c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYO3A FARP1 PKHD1 SLC5A8 ALPK2

5.16e-05186965f28d72b47624b69a580b4429e2be560a26898591
ToppCellCOVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type

FARP1 PKHD1 SLC5A8 ALDOB ALPK2

5.29e-05187965738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor

THSD4 KRT7 GLCCI1 TTLL7 FARP1

5.29e-0518796577f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCellCOPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class

KRT7 TCIM FREM2 EHF SLC5A8

5.43e-05188965eb6d79d733b53f64ca615bb777c64ed456866549
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TTLL7 MYO3A FARP1 PKHD1 ALPK2

5.56e-051899653b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RUBCNL TCIM KCNS3 TMEM108 HOMER3

5.56e-0518996578cf414b98bcb19deb934409acddaad1cd51b67f
ToppCellIPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class

KRT7 TCIM EHF TMEM108 MUC4

5.56e-05189965f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor

THSD4 KRT7 GLCCI1 TTLL7 FARP1

5.56e-051899655a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCellILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

THSD4 PRR5 CCDC80 MAP3K1 HOMER3

5.70e-051909659ce301841ce9486701fa28eb2a9929e35d476878
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KRT7 TCIM MAP3K1 EHF PKHD1

5.70e-051909653fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 MUC16 EHF SLC5A8 MUC4

5.70e-0519096523f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCellBL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

KRT7 TCIM EHF KCNS3 SLC5A8

5.70e-05190965f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 MUC16 EHF SLC5A8 MUC4

5.70e-051909653c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 CCDC80 SLC5A8 CPLANE1 MUC4

5.70e-051909652fdc024d3d673a0134b74b4c5a63afe924995730
ToppCellcellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

KRT7 MUC16 EHF SLC5A8 MUC4

5.85e-0519196530e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb
ToppCellcellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

KRT7 MUC16 EHF SLC5A8 MUC4

5.85e-0519196541d2f5278f6d5f52a5bdf4f3df70969481c00162
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD4 ROR2 CCDC80 IGSF10 GLI2

5.85e-0519196514057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 MUC16 CCDC80 SLC5A8 MUC4

5.85e-05191965cd709bbcd320373468ea7f058ee5fda8a067b5d0
ToppCellIPF-Epithelial-Club|World / Disease state, Lineage and Cell class

KRT7 TCIM EHF TMEM108 MUC4

5.85e-051919653c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 MUC16 CCDC80 SLC5A8 MUC4

5.85e-0519196514851529025cfc2b665f71ebad04150ec543da7a
ToppCellbackground-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells)

THSD4 KRT7 ARHGEF10 EHF PKHD1

5.85e-0519196599aa8d685767a72bef9f05e7cc8913126a048c39
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KRT7 TCIM MAP3K1 EHF PKHD1

5.85e-051919655a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KRT7 TCIM MAP3K1 EHF PKHD1

5.85e-0519196555ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

GLCCI1 FREM2 LRIG1 FARP1 EHF

5.85e-05191965e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 MUC16 CCDC80 SLC5A8 MUC4

5.85e-05191965e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROR2 CCDC80 IGSF10 GLI2 TMEM108

5.99e-051929656f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPG2 TCIM CCDC80 RALGAPA2 GARRE1

5.99e-051929652bfac6b3956265205ca47d06888851ed68b65999
ToppCellAdult-Epithelial|Adult / Lineage, Cell type, age group and donor

THSD4 GLCCI1 LRIG1 FARP1 EHF

5.99e-05192965efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPG2 TCIM CCDC80 RALGAPA2 GARRE1

5.99e-05192965d525f7f088a53110912600a7c9f6d33b9270d534
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROR2 CCDC80 IGSF10 GLI2 TMEM108

5.99e-05192965deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT7 TCIM EHF SLC5A8 MUC4

6.14e-05193965463274f394757fb2570ae885d58e1f9fa7e60c4a
ToppCellEpithelial-club_cell|World / Lineage, Cell type, age group and donor

GLCCI1 LRIG1 FARP1 EHF MUC4

6.14e-051939652bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KRT7 GLCCI1 MAP3K1 EHF PKHD1

6.14e-05193965263d185af6ed80e639f864e4966268e0862c61dc
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROR2 CCDC80 IGSF10 GLI2 TMEM108

6.14e-05193965fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KRT7 GLCCI1 MAP3K1 EHF PKHD1

6.14e-0519396580e058c224749b5fe0ba3e944b48317c2371cb63
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

KRT7 GLCCI1 MAP3K1 EHF PKHD1

6.14e-05193965b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCelldroplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

THSD4 KRT7 EHF SLC5A8 MUC4

6.14e-0519396522ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCellfacs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDB1 GLCCI1 MAP3K1 RIPOR1 UTY

6.30e-05194965f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPG2 TCIM CCDC80 RALGAPA2 GARRE1

6.30e-05194965c8b9551b93a5aed62154b487db90130604a6125c
ToppCelldroplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT7 TCIM EHF SLC5A8 MUC4

6.30e-051949650ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT7 CLCN3 EHF SLC5A8 MUC4

6.30e-05194965550e61a40be2baa59520aaf5912bb99ad094ba15
ToppCellfacs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDB1 GLCCI1 MAP3K1 RIPOR1 UTY

6.30e-05194965cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROR2 CCDC80 IGSF10 GLI2 TMEM108

6.30e-0519496560622bd2f75bfe4c37f721cb12f03dab33f2f58d
DiseasePolydactyly

FREM2 NPHP3 PNPLA6 GLI2 CPLANE1

2.86e-05117895C0152427
DiseasePolyneuropathy

NMNAT2 PNPLA6

5.38e-054892C0152025
Diseasebipolar disorder, cytomegalovirus seropositivity

ROR2 NFIL3

5.38e-054892EFO_0007037, MONDO_0004985
DiseaseBasal Cell Nevus Syndrome

GLI2 PTCH2

8.94e-055892C0004779
Diseasecortical thickness

THSD4 HSPG2 DNAAF9 RFX4 JMJD1C MAP3K1 KCTD3 PKHD1 KCNS3 TMEM108 FIGLA ULK2

1.28e-0411138912EFO_0004840
Diseaseosteopetrosis (implicated_via_orthology)

CLCN3 CLCN7

1.87e-047892DOID:13533 (implicated_via_orthology)
DiseaseDrug-induced agranulocytosis, response to clozapine

NMNAT2 GRM7 FARP1

2.80e-0442893GO_0097338, HP_0012235
DiseaseAutosomal Recessive Polycystic Kidney Disease

NPHP3 PKHD1

3.19e-049892C0085548
Diseasecystic fibrosis, lung disease severity measurement

EHF MUC4

3.19e-049892EFO_0007744, MONDO_0009061
Diseasecolorectal cancer

THSD4 GRM7 LRIG1 ARHGEF10 KCNS3 ALDOB KCNT1 GARRE1

4.85e-04604898MONDO_0005575
DiseaseHermansky-Pudlak syndrome (implicated_via_orthology)

CCZ1B CCZ1

8.00e-0414892DOID:3753 (implicated_via_orthology)
Diseasediffuse idiopathic skeletal hyperostosis

ROR2 NFIL3

9.21e-0415892EFO_0007236
Diseasecholangiocarcinoma (is_marker_for)

KRT7 MUC16 MUC4

9.68e-0464893DOID:4947 (is_marker_for)
Diseasecognitive function measurement

NMNAT2 SZT2 GRM7 GLCCI1 JMJD1C TTLL7 ARMS2 MYO3A ARHGEF10 TTLL2 FARP1 PKHD1

1.23e-0314348912EFO_0008354
Diseaseresponse to alcohol

TCIM SIPA1L1 PKHD1

1.53e-0375893EFO_0005526
Diseaselate-onset Alzheimers disease

THSD4 CCZ1B RHBDF1 PICALM LRIG1

1.93e-03292895EFO_1001870
DiseaseOvarian Serous Adenocarcinoma

RAF1 MYO3A

2.18e-0323892C1335177
Diseasetriacylglycerol 52:6 measurement

GRM7 NR2C2AP

2.58e-0325892EFO_0010418
Diseaseresponse to methotrexate, drug-induced liver injury

MYO3A FARP1

2.79e-0326892EFO_0004228, GO_0031427
Diseasefacial morphology measurement

THSD4 ROR2 GRM7 EYS PKHD1 KCNS3

2.90e-03466896EFO_0007841
DiseaseParkinson disease

TCIM TMC3 RFX4 CLCN3 KCNS3

2.91e-03321895MONDO_0005180

Protein segments in the cluster

PeptideGeneStartEntry
MASLSSSVVPVSFIS

ARMS2

21

P0C7Q2
ATVSSRPSHDSRVMS

ARHGEF10

676

O15013
APHVMTSSTVEVSKS

ADGRG4

2026

Q8IZF6
FSRKTMSPSTTDHTL

ADGRG4

2126

Q8IZF6
MSPLFTSTFTLNISH

ALPK2

886

Q86TB3
MATVTALHRTVPAAV

ALDOB

251

P05062
TISHTQATGSRSVPM

GLCCI1

266

Q86VQ1
TVATSTHRTTVPSTM

CDHR4

656

A6H8M9
TFLPETRIMTSVTFT

ECD

251

O95905
TTAFPHVAATLSIMD

ATXN7L1

581

Q9ULK2
SRAVTVAARPMTTTA

CCDC80

366

Q76M96
RSTSTPNVHMVSTTL

RAF1

256

P04049
SFSLSSTEVHMVRPG

RUBCNL

126

Q9H714
SMPIRIESSSSHVAE

HSPG2

2726

P98160
TRVIRDMTLHSAPSF

RFX4

436

Q33E94
ALNRVTASHPFMTAV

ORC4

286

O43929
RFPHSEETTTMSRST

MUC16

5896

Q8WXI7
TVTQRFSHSEMTTLV

MUC16

8231

Q8WXI7
FPESRFTMSVTESTH

MUC16

10246

Q8WXI7
ISTIPSTAMHTRSTA

MUC4

4291

Q99102
SVVLSAAHTVAARMS

PNPLA6

621

Q8IY17
MTLVSPSGRTISFHS

OR10G7

81

Q8NGN6
QTAHSTSPMRSVLLT

PTPRN

566

Q16849
MTLVSPSGRAISFHS

OR10G4

81

Q8NGN3
TSVSHMPIRTSAATL

EYS

1366

Q5T1H1
FTKTPHDITIRTTTM

LRIG1

601

Q96JA1
MSTVIHIRSETSVPD

IFITM2

41

Q01629
MSIHFSSPVFTSRSA

KRT7

1

P08729
AMVSVIGTATTHLSP

MMS19

656

Q96T76
CSVPHRTTDVAMLVT

LRRC3

196

Q9BY71
PTHLTVSSTNTLRSM

JMJD1C

1186

Q15652
VLSHPASFTSSVIMS

FREM2

2756

Q5SZK8
ITAFHSQTLPFMATR

FER1L4

91

A9Z1Z3
LSITTELTHPSNMRF

KCNT1

896

Q5JUK3
TVGSTSPMTSRHRVT

DSG4

1016

Q86SJ6
MSTAREQPIFSTRAH

HOMER3

1

Q9NSC5
TSHSLTAREVMSTPV

CLCN7

621

P51798
CVSVTVPAMLSHFIS

OR3A4P

76

P47883
MVTVTCRSTLHSPLY

OR4L1

46

Q8NH43
PSMVHSSLTPFSVQV

NFIL3

371

Q16649
MSIPTSPTRISFHSI

CRHR2

391

Q13324
RSVHSSPTLSMISAA

GLI2

131

P10070
QRMHTFITSLSSVGI

KCNS3

446

Q9BQ31
ATSTVEVIFHVSTRM

RALGAPA2

1711

Q2PPJ7
PHSVSVATAQMARIT

IGLV3-12

26

A0A075B6K2
MSSITFPAVSALVSR

MFSD14A

346

Q96MC6
RTVMIAHISPASSAF

KIF19

316

Q2TAC6
RSTSTPNVHMVSTTA

ARAF

211

P10398
KVSPFHFTTLSTSVM

IGSF10

1246

Q6WRI0
SLNLSPVMSRSHSVV

E2F7

821

Q96AV8
TTLRFLDSLSPSVHM

CPLANE1

421

Q9H799
MEVIRSATSSASRPH

FARP1

1021

Q9Y4F1
FCRAQISMTTTSHLP

EHF

166

Q9NZC4
PLVTRHNSAATAMVT

GARRE1

666

O15063
TVHMRKTPSVSLTSV

CCZ1

391

P86791
TVHMRKTPSVSLTSV

CCZ1B

391

P86790
HFAISSISQEPVMRT

DNAAF9

711

Q5TEA3
VVSRPSSKRMTSHTT

MAP7D3

826

Q8IWC1
VVTAATMSSRLSHKP

GRM7

866

Q14831
SRIPSFTQLHSTMTR

C2orf66

6

Q6UXQ4
CRHSVMSTTEIISPT

FIGLA

186

Q6QHK4
TFTVHRSPVTKIMLS

KCTD3

416

Q9Y597
IIPRSILMTTFESSH

DDB1

586

Q16531
MTHSLVCPETVSRVS

NR2C2AP

1

Q86WQ0
MTLVSPSGRAISFHS

OR10G9

81

Q8NGN4
ITVIIMYIRPSSSHS

OR5B17

251

Q8NGF7
LSSARMVTTVPHVFS

MAP3K1

821

Q13233
VSRSSAHMVSRFLLP

SZT2

2541

Q5T011
SHRSTSQILPSMSVS

UTY

821

O14607
EIASMRHVTTSTLLT

RGSL1

721

A5PLK6
RSRTPMTFTTHIEDV

TMC3

836

Q7Z5M5
GTTTTFPMSNHTRER

STK38L

6

Q9Y2H1
ILSHFVGRPMSTSSE

NPHP3

556

Q7Z494
TSIRRHSVSEMTSCP

PRR5

276

P85299
QSFARVTTSMTVAIH

PTCH2

1151

Q9Y6C5
SMSSSSRIVTHDIPI

HUS1

121

O60921
FLRSVSMPAETAHIS

RHBDF1

46

Q96CC6
MSSRHSASPVVFTSA

SIPA1L1

1426

O43166
RMTAVPVALSLTASF

SLC5A8

51

Q8N695
TPVSALLHSSTMVVA

MT-ND5

241

P03915
RSGVSIHLALTVMVS

PKHD1

3556

P08F94
ITAAFTMIGTSTHLS

ROR2

206

Q01974
LRSILDMSPFTVTDH

CLCN3

751

P51790
STFTTRTPTHEMFVG

PICALM

456

Q13492
MSFLRITPSTHSSVS

RNF148

1

Q8N7C7
QLPTCFMSTHRIVTE

THEMIS2

106

Q5TEJ8
HVMERSLSPSLSSVD

FSBP

186

O95073
RTSSFRMTEHNSVKP

TTLL2

126

Q9BWV7
APTCTHMFLRTRTTS

ULK2

736

Q8IYT8
HMFLRTRTTSVGPSN

ULK2

741

Q8IYT8
MAPVKISHVVSFSSQ

XNDC1N

1

Q6ZNB5
IFSMALHPSETRTLV

WDR76

316

Q9H967
RPAHSTSVSMSRLSL

PHF8

506

Q9UPP1
STEVHVRAIKTMTSF

TAS2R8

226

Q9NYW2
TRSVVCMTNHVSSLP

THSD4

816

Q6ZMP0
SHQAVIMSTSLRVSP

TCIM

6

Q9NR00
LSRVSRMFSVAHPAA

RIPOR1

56

Q6ZS17
MISVSRPTSASRSHS

TTLL7

626

Q6ZT98
GHATPVSSLMFTTIR

WDR43

206

Q15061
VTAPHSSTRHTSVVM

TMEM108

51

Q6UXF1
MSSFKHQRIVTTPTE

MYO3A

1371

Q8NEV4
INHPMSVVSSTKSRL

NMNAT2

261

Q9BZQ4